Gilead develops solid tumour cell therapy with Gadeta
Gilead has option to buy biotech if things go well
Gilead has option to buy biotech if things go well
New approach tackles reserve of HIV within the body
Federal judge throws out Merck’s patent claim against Gilead
US hospitals struggle to provide approved autologous therapies
Fast reviews set up showdown with Gilead
Gilead hopes CDL technology will create therapies targeting solid tumours
Cancer cell therapy approved for aggressive blood cancer